High Classification of Chronic Heart Failure Increases Risk of Overactive Bladder Syndrome and Lower Urinary Tract Symptoms
Tzu Chi University, Hua-lien, Taiwan, Taiwan Urology
(Impact Factor: 2.19).
11/2011; 79(2):260-5. DOI: 10.1016/j.urology.2011.10.020
To assess the urologic symptoms among patients with chronic heart failure (CHF) and to explore whether a higher classification of CHF increases the risk associated with overactive bladder syndrome (OAB) and lower urinary tract symptoms.
A total of 214 ambulatory patients with CHF (129 men and 85 women) and 378 age-matched subjects (222 men and 156 women) were enrolled in the present study. The urologic symptoms were evaluated using the Overactive Bladder Symptom Score (OABSS) and International Prostate Symptom Score (IPSS) from January to June 2010.
Compared with the controls, the patients with CHF had a significantly greater mean OABSS (4.6±3.6 vs 3.4±3.1, P<.001), total IPSS (8.3±6.9 vs 6.9±7.6, P=.021), and storage IPSS (4.8±3.5 vs 3.7±3.3, P<.001). Of the patients with CHF, 34.1% had moderate/severe OAB symptoms (OABSS≥6), and 43.5% had moderate/severe lower urinary tract symptoms (IPSS≥8). Compared with patients who had New York Heart Association (NYHA) class I CHF, the patients with NYHA class III CHF had a significantly greater OABSS and total, storage, and voiding IPSSs. Patients with NYHA class II CHF did not. A greater body mass index and stroke were significantly associated with the OABSS and storage IPSS, and pulmonary disease was significantly associated with the voiding IPSS.
The patients with CHF had more storage urinary symptoms suggestive of OAB than did the age-matched controls. Among the patients with CHF, greater NYHA class heart function was significantly associated with OAB and lower urinary tract symptoms.
Available from: Aih-Fung Chiu
[Show abstract] [Hide abstract]
To assess the occurrence and the associated risk factors for nocturia among middle-aged and elderly people from public health centers in southern Taiwan.
Materials and methods:
Data were part of our previous cross-sectional study which used a self-administered questionnaire for the assessment of lower urinary tract symptoms. A total of 1011 responders who were at least 40 years of age were enrolled from any of four local public health centers for any reason in Pingtung County, Taiwan. Nocturia, as a dependent variable, was defined as two or more episodes per night. Covariables included age, gender, and chronic illnesses (obesity, hypertension, diabetes, cardiovascular disease, and stroke). Multivariate logistic regression was applied to determine the risk factors associated with nocturia. A p-value of less than 0.05 was considered statistically significant.
About 38.1 % (385/1011) of the participants reported having nocturia ≥ 2 episodes/night, and the occurrence of nocturia increased with advanced age. More than half (51.2 %, 197/385) participants with nocturia perceived at least ″a bit of a problem″ on the sleep quality. The multivariate logistical regression showed that the independent risk factors for nocturia were age (OR:1.06, CI:1.05-1.08), hypertension (OR:1.58, CI:1.16-2.16) and diabetes (OR:1.59, CI:1.03-2.45) and obesity (OR:1.47, CI:1.02-2.10), while a borderline effect on nocturia was produced by cardiovascular disease (OR:1.66, CI: 0.98-2.79) and stroke (OR:2.75, CI:0.88-8.64).
Several chronic illnesses coexisted with nocturia. Health care providers need to be aware of an increased risk of nocturia among people with certain chronic illnesses, and provide appropriate health care.
International braz j urol: official journal of the Brazilian Society of Urology 11/2012; 38(6):818-24. DOI:10.1016/j.juro.2013.07.066 · 0.88 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Overactive bladder (OAB) is a highly prevalent clinical condition in both men and women, and rates tend to increase with advancing age. A variety of different evaluation methods have been developed to measure both objective and subjective parameters of the condition. OAB has been associated with negative clinical outcomes, particularly in older adults, including depression, social isolation, and impairments of both general and health-related quality of life. Options for treatment include behavioral therapies, medications, and surgical treatments such as chemodenervation. Combined symptoms of OAB and benign prostatic enlargement have recently gained increased research attention. This article reviews recently published literature on epidemiology, evaluation, clinical impacts, and management of OAB, with a focus on elderly men.
Current Urology Reports 08/2013; 14(5). DOI:10.1007/s11934-013-0367-0 · 1.51 Impact Factor
[Show abstract] [Hide abstract]
ABSTRACT: Nocturia is such a commonplace occurrence in the lives of many older adults that it is frequently overlooked as a potential cause of sleep disturbance. The aim of the present study was to evaluate the prevalence of nocturia among elderly men living in a rural area in Egypt, and its impact on sleep quality and health-related quality of life (HRQoL).
This was a cross-sectional study. A total of 1200 elderly men participated in the survey. The Pittsburgh Sleep Quality Index (PSQI) Arabic version and the short form-36 (SF-36) were used in this survey.
The prevalence of nocturia in the studied participants (≥1 void/night) was 63.5%. With the criterion (≥2 voids/night) the prevalence was 46.0%. Multivariate logistic regression analysis showed that nocturia is an independent risk factor of poor sleep quality (OR 5.08), and poor sleep is an independent risk factor of the poor physical component of QoL (OR 17.6) and the mental component of QoL (OR 3.2).
Nocturia is widely prevalent among elderly men living in a rural area in Egypt. The adverse effect of nocturia on QoL is related to poor sleep. Geriatr Gerontol Int 2013; ●●: ●●-●●.
Geriatrics & Gerontology International 09/2013; 14(3). DOI:10.1111/ggi.12145 · 2.19 Impact Factor
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.